AUSTIN (KXAN) - Thousands of women across the county are currently battling breast cancer.
According to the American Cancer Society, 40,000 women die every year from the disease.
But, an exciting new clinical research trial done right here in Austin is showing some promise when it comes to fighting the disease.
"You want to spend the remainder of your life to have a good life," said cancer patient Dao Tran.
In 2005, Tran received some bad news: She had breast cancer. After a mastectomy and chemotherapy, the cancer was gone.
"And then in 2009, my cancer came back to my sternum and lung," said Tran.
The prognosis this time: incurable cancer known as triple negative breast cancer.
"Their survival is quite limited, with an average survival of right around a year," said Texas Oncology Medical Oncologist Dr. Debra Patt.
That led Tran and her family to move from New York City to Austin to take part in Patt's clinical trail at Texas Oncology for an experimental drug called Iniparib . The first round of clinical trials had already shown positive results.
"The survival among the patients who received the targeted therapy, which is called Iniparib -- which is a PARP inhibitor -- lived almost twice as long," said Patt.
Women taking part in the trial who received Iniparib in addition to chemo lived an average of 12 months, compared to just seven months in the chemo-alone group. While it may sound like a small difference, doctors said it shows big strides in treating the disease.
"Your cell is smart. It can repair itself, but PARP inhibitors actually prevent the cell from repairing itself and renders the chemotherapy more effective," said Patt.
This means Iniparib could be used to treat a variety of cancers that require chemo. Plus, patients like Tran have seen their tumor shrink and have had mild side effects, such as fatigue and nausea.
"It does not give you side effects that bad," said Tran.
But, it does give patients hope for a better future.
"If everything goes as well as we think they do, it could be FDA-approved as early as late this year or early next year," said Patt.
Right now, Texas Oncology is conducting the third clinical trial .
Mack Brown's attorney and the university's new athletics director say the Texas coach has not resigned, denying a report that Brown was ready to step down after 16 seasons with the Longhorns.
A large majority of the crowd that poured into Austin City Hall on Tuesday night was disappointed with the Parks and Recreation Department's decision to approve a smaller off leash area at Auditorium Shores.
The top prosecutor in Travis County found herself on the witness stand Tuesday to answer questions about her professional and personal history along with her history of alcohol.
A proposal to build a highway in south Austin is getting mixed reviews from neighbors.
An Austin man has been convicted in a human smuggling case in which a teen says she was forced to wear revealing clothes and sexually assaulted while bound for New Jersey.
An historic early December cold spell is slowly waning, but temperatures will remain well below average for a couple more days.